IRIS
SALOMONE, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.641
EU - Europa 3.056
AS - Asia 2.554
SA - Sud America 500
AF - Africa 341
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 7
Totale 13.110
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.382
SG - Singapore 1.253
IT - Italia 947
CN - Cina 940
IE - Irlanda 723
UA - Ucraina 610
BR - Brasile 454
CA - Canada 236
RU - Federazione Russa 199
DE - Germania 172
CI - Costa d'Avorio 167
SN - Senegal 128
SE - Svezia 107
VN - Vietnam 94
KR - Corea 59
GB - Regno Unito 56
IN - India 53
FR - Francia 45
FI - Finlandia 42
NL - Olanda 22
BE - Belgio 21
BD - Bangladesh 20
CH - Svizzera 19
UZ - Uzbekistan 15
GR - Grecia 14
JP - Giappone 14
TR - Turchia 14
ZA - Sudafrica 14
IQ - Iraq 13
AR - Argentina 12
AT - Austria 12
CZ - Repubblica Ceca 12
IR - Iran 12
ES - Italia 11
MX - Messico 11
PK - Pakistan 11
AU - Australia 10
EC - Ecuador 10
PL - Polonia 10
CO - Colombia 9
HK - Hong Kong 9
LB - Libano 9
MA - Marocco 8
EG - Egitto 7
EU - Europa 7
AZ - Azerbaigian 6
BG - Bulgaria 5
HR - Croazia 5
IL - Israele 5
KE - Kenya 5
TN - Tunisia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
JM - Giamaica 4
NG - Nigeria 4
PY - Paraguay 4
VE - Venezuela 4
BA - Bosnia-Erzegovina 3
ID - Indonesia 3
LT - Lituania 3
RS - Serbia 3
SA - Arabia Saudita 3
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
JO - Giordania 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LU - Lussemburgo 2
PE - Perù 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BY - Bielorussia 1
CL - Cile 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
GA - Gabon 1
IM - Isola di Man 1
LK - Sri Lanka 1
MD - Moldavia 1
MK - Macedonia 1
MT - Malta 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
QA - Qatar 1
RO - Romania 1
SR - Suriname 1
SV - El Salvador 1
UY - Uruguay 1
Totale 13.110
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.011
Chandler 916
Singapore 752
Dublin 722
Jacksonville 686
Dallas 329
Chicago 328
Boardman 325
Catania 279
Cambridge 200
Lawrence 198
Andover 195
Nanjing 180
Toronto 169
Abidjan 167
Houston 164
Ashburn 158
Hefei 149
Dakar 128
Beijing 122
Wilmington 110
Des Moines 87
Civitanova Marche 83
San Mateo 83
Dong Ket 65
Shenyang 63
Los Angeles 62
Nanchang 62
Seoul 59
Council Bluffs 57
Grafing 53
Hebei 51
Ottawa 49
The Dalles 49
Bremen 47
Saint Petersburg 45
Columbus 43
Messina 41
Changsha 38
São Paulo 38
Jiaxing 35
Munich 30
Tianjin 30
Falls Church 27
Palermo 26
Seattle 24
Dearborn 22
Helsinki 21
Norwalk 19
Rome 18
Florence 17
Milan 17
Redwood City 17
Jinan 16
New York 16
Rio de Janeiro 16
Turku 16
Brooklyn 15
Lissone 15
Moscow 15
Brussels 14
Curitiba 14
Pune 14
Hangzhou 13
Guangzhou 12
Hanoi 12
Kunming 12
Liberty Lake 12
Washington 12
Belo Horizonte 11
Irvine 11
Stockholm 11
Boston 10
Ningbo 10
Padova 10
Tappahannock 10
Tokyo 10
Amsterdam 9
Atlanta 9
Campobasso 9
Ho Chi Minh City 9
Sesto Fiorentino 9
Turin 9
Mumbai 8
Phoenix 8
San Francisco 8
Vicenza 8
Baghdad 7
Campinas 7
Den Haag 7
Johannesburg 7
Kraainem 7
Baku 6
Caltanissetta 6
Frankfurt Am Main 6
Kochi 6
Recife 6
Shanghai 6
Aci Catena 5
Charlotte 5
Totale 9.140
Salva come PNG Salva come JPEG
Nome #
A novel arousal-based individual screening reveals susceptibility and resilience to PTSD-like phenotypes in mice 191
Current drug treatments targeting dopamine D3 receptor 178
Dopaminergic-GABAergic interplay and alcohol binge drinking 164
Aflibercept, bevacizumab and ranibizumab prevent glucose-induced damage in human retinal pericytes in vitro, through a PLA2/COX-2/VEGF-A pathway 158
Fluoxetine and Vortioxetine Reverse Depressive-Like Phenotype and Memory Deficits Induced by Aβ1-42 Oligomers in Mice: A Key Role of Transforming Growth Factor-β1 131
The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans 122
Anti-VEGF agents inhibit activation of PLA2/COX-2 and expression of VEGF-A induced by high glucose, in human retinal pericytes in vitro 121
Apixaban enhances vasodilatation mediated by protease-activated receptor 2 in isolated rat arteries 118
Sulodexide prevents activation of the PLA2/COX-2/VEGF inflammatory pathway in human retinal endothelial cells by blocking the effect of AGE/RAGE 118
Activation of the VEGF-A/ERK/PLA2 axis mediates early retinal endothelial cell damage induced by high glucose: New insight from an in vitro model of diabetic retinopathy 116
1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats 114
Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α 2b Plus Ribavirin: Effect on Work Performance; A Randomized Clinical Trial. 111
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 109
Antioxidant Activity of Fluoxetine and Vortioxetine in a Non-Transgenic Animal Model of Alzheimer’s Disease 108
Buspirone counteracts MK-801-induced schizophrenia-like phenotypes through dopamine D3receptor blockade 106
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 106
Validation of the Glasgow Antipsychotic Side-Effect Scale (GASS) in an Italian Sample of Patients with Stable Schizophrenia and Bipolar Spectrum Disorders 104
A new human blood–retinal barrier model based on endothelial cells, pericytes, and astrocytes 104
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 102
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 100
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 100
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 99
Epigenetic drugs for Alzheimer's disease: hopes and challenges 98
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 92
P2X7 receptor antagonism: implications in diabetic retinopathy 91
Blink reflex recovery cycle to differentiate progressive supranuclear palsy from corticobasal syndrome 91
Isoflavones: estrogenic activity, biological effect and bioavailability 90
Particle identification with the 4 pi CHIMERA detector array 90
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 90
Ambiguities in dietary antioxidant supplementation compared to calcium channel blockers therapy 86
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 85
A comparison of the potency of selective L-calcium channel blockers in human coronary and internal mammary arteries exposed to serotonin 84
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 84
Pleiotropic effects of glitazones: a double edge sword? 83
Activity of dihydrothienopyridine S312 enantiomers on L-type calcium channels in isolated rat aorta and cerebral microvessels 83
Controversies in Glaucoma: Current Medical Treatment and Drug Development 82
Effects of novel hybrids of caffeic acid phenethyl ester and NSAIDs on experimental ocular inflammation 82
Dopamine D3 Receptor, Cognition and Cognitive Dysfunctions in Neuropsychiatric Disorders: From the Bench to the Bedside 81
Clinical course of N-methyl-D-aspartate receptor encephalitis and the effectiveness of cyclophosphamide treatment 81
Isolation, cultivation, and characterization of primary bovine cochlear pericytes: A new in vitro model of stria vascularis 80
Regulation of intraocular pressure in mice: structural analysis of dopaminergic and serotonergic systems in response to cabergoline 79
Effects of phenformin on the proliferation of human tumor cell lines 79
Retinal protection and distribution of curcumin in vitro and in vivo 79
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice 79
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 79
Gut microbiota alterations promote traumatic stress susceptibility associated with p-cresol-induced dopaminergic dysfunctions 78
Genetic blockade of the dopamine D3 receptor enhances hippocampal expression of PACAP and receptors and alters their cortical distribution 78
Therapeutic Challenges of Post-traumatic Stress Disorder: Focus on the Dopaminergic System 78
Off-label use of drugs and adverse drug reactions in pediatric units: A prospective, multicenter study 78
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 77
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 77
Clinical and CN-SFEMG evaluation of neostigmine test in myasthenia gravis 77
CALCIUM ANTAGONISTS AND ENDOTHELIAL FUNCTION: FOCUS ON NITRIC OXIDE AND ENDOTHELIN 76
PLGA-PEG NANOPARTICLES LOADED WITH ANTIPSYCHOTIC AGENTS: INFLUENCE OF DRUG MOLECULES ON THE CRYOPROTECTIVE EFFECT OF SUCROSE. 76
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 76
Dopamine outside the brain: The eye, cardiovascular system and endocrine pancreas 76
Long-term incubation with beta-amyloid peptides impairs endothelium-dependent vasodilatation in isolated rat basilar artery 75
Abnormal vascular responses and cerebral reperfusion injury in ApoE-deficient mice on Western diet 75
Asymmetry index of Blink Reflex Recovery Cycle differentiates Parkinson’s disease from atypical Parkinsonian syndromes 75
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 73
Exogenous nitric oxide mediates changes of vascular contractility induced by activated glia 73
Dopamine, cognitive impairments and second-generation antipsychotics: From mechanistic advances to more personalized treatments 73
Lipoprotein(a) serum levels in diabetic patients with retinopathy 72
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 72
A THERAPEUTIC DOSAGE OF AMLODIPINE PREVENTS VASCULAR HYPOREACTIVITY INDUCED IN RATS BY LIPOPOLYSACCHARIDE 72
Regulation of endothelial nitric oxide synthase and postnatal angiogenesis by Rac1 71
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 71
Role of phospholipases A2 in diabetic retinopathy: in vitro and in vivo studies. 71
Analytical and experimental pharmacology, challenges ahead 71
Analysis of sphingosine 1-phosphate receptors involved in constriction of isolated cerebral arteries with receptor null mice and pharmacological tools 71
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 71
Potential drug mechanism(s) targeting the contractile status of hepatic stellate cells 70
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 70
Forehead Tremor: A Clinical Presentation of Myasthenia Gravis? 70
Preclinical study of the action of a calcium channel blocker during salt load 69
Vascular sphingosine-1-phosphate S1P1 and S1P3 receptors 69
Preliminary pharmacokinetic and clinical evaluation of ofloxacin in dental and oral cavity diseases 69
Safety profile assessment of buflomedil: an overview of adverse reactions between 1975 and 2011 69
Multidisciplinary Approach to the Diagnosis and In-Hospital Management of COVID-19 Infection: A Narrative Review 69
Role of magnesium, coenzyme Q10, riboflavin, and vitamin B12 in migraine prophylaxis 68
Linking the Price of Cancer Drug Treatments to Their Clinical Value 67
Effects of PPARγ ligands on vascular tone 67
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 67
Action of the calcium channel blocker lacidipine on cardiac hypertrophy and endothelin-1 gene expression in stroke-prone hypertensive rats 67
Evaluation of Neostigmine responsiveness with concentric-needle single fiber electromyography in myasthenia gravis: A comparative study 67
INHIBITION BY BOSENTAN, AN ENDOTHELIN ANTAGONIST, OF THE HYPERSENSITIVITY TO CA2+ CHANNEL ACTIVATOR EVOKED BY SALT-LOADING IN BASILAR ARTERY OF STROKE-PRONE SPONTANEOUSLY HYPERTENSIVE RATS 67
Cistus incanus and Cistus monspeliensis inhibit the contractile response in isolated rat smooth muscle 66
MicroRNAs in the vitreous humor of patients with retinal detachment and a different grading of proliferative vitreoretinopathy: A pilot study 66
Sphingosine-1-phosphate and Sphingosine-1-phosphate receptors in the cardiovascular system: pharmacology and clinical implications 65
Migraine: an overview 65
Ocular drug delivery: a clue from nanotechnology 65
Work Productivity and Activity Impairment in Colorectal Cancer Patients Treated with Capecitabine 65
Clinical pharmacology of novel anti-Alzheimer disease modifying medications. 65
Centenarians and supercentenarians: a black swan. Emerging social, medical and surgical problems 64
Facilitation of the vasorelaxant action of calcium antagonists by basal nitric oxide in depolarized artery 64
Effects of chronic sumatriptan and zolmitriptan treatment on 5-HT receptor expression and function in rats 64
Ocular allergy 64
Role of nitric oxide in the contractile response to 5-hydroxytryptamine of the basilar artery from Wistar Kyoto and stroke-prone rats 63
eNOS phosphorylation modulates vascular reactivity and stroke outcome in S1179D and S1179A knock-in mice 63
Farmaci della coaugulazione 63
Totale 8.488
Salva come PNG Salva come JPEG
Categoria #
all - tutte 52.211
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 52.211
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.168 0 0 147 5 300 52 185 10 152 27 160 130
2021/20221.549 198 211 28 25 227 53 217 57 148 8 59 318
2022/20232.734 232 124 40 279 277 463 30 511 621 15 88 54
2023/2024992 60 149 54 73 36 208 17 62 8 17 187 121
2024/20254.022 51 626 214 248 911 464 115 174 297 389 282 251
2025/20261.059 463 365 231 0 0 0 0 0 0 0 0 0
Totale 13.477